AR031709A1 - Compuestos ciclicos fusionados, las composiciones farmaceuticas que los contienen, los compuestos intermediarios en la preparacion de dichos compuestos ciclicos y los procedimientos para preparar dichos compuestos intermediarios - Google Patents

Compuestos ciclicos fusionados, las composiciones farmaceuticas que los contienen, los compuestos intermediarios en la preparacion de dichos compuestos ciclicos y los procedimientos para preparar dichos compuestos intermediarios

Info

Publication number
AR031709A1
AR031709A1 ARP010103100A ARP010103100A AR031709A1 AR 031709 A1 AR031709 A1 AR 031709A1 AR P010103100 A ARP010103100 A AR P010103100A AR P010103100 A ARP010103100 A AR P010103100A AR 031709 A1 AR031709 A1 AR 031709A1
Authority
AR
Argentina
Prior art keywords
substituted
cr7r7
heterocycle
aryl
compounds
Prior art date
Application number
ARP010103100A
Other languages
English (en)
Spanish (es)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AR031709A1 publication Critical patent/AR031709A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/655Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP010103100A 2000-06-28 2001-06-28 Compuestos ciclicos fusionados, las composiciones farmaceuticas que los contienen, los compuestos intermediarios en la preparacion de dichos compuestos ciclicos y los procedimientos para preparar dichos compuestos intermediarios AR031709A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21439200P 2000-06-28 2000-06-28
US28461701P 2001-04-18 2001-04-18
US28443801P 2001-04-18 2001-04-18

Publications (1)

Publication Number Publication Date
AR031709A1 true AR031709A1 (es) 2003-10-01

Family

ID=27395986

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103100A AR031709A1 (es) 2000-06-28 2001-06-28 Compuestos ciclicos fusionados, las composiciones farmaceuticas que los contienen, los compuestos intermediarios en la preparacion de dichos compuestos ciclicos y los procedimientos para preparar dichos compuestos intermediarios

Country Status (9)

Country Link
KR (1) KR20030014407A (pl)
CN (1) CN1443187A (pl)
AR (1) AR031709A1 (pl)
CZ (1) CZ20024250A3 (pl)
IL (1) IL152890A0 (pl)
PE (1) PE20030186A1 (pl)
PL (1) PL366565A1 (pl)
TR (1) TR200202702T2 (pl)
UY (1) UY26809A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9409856B2 (en) 2005-11-28 2016-08-09 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
EA201500845A1 (ru) * 2005-11-28 2016-04-29 Джи Ти Икс, ИНК. Агенты, связывающиеся с ядерными рецепторами
US8546451B2 (en) 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
CN102875556B (zh) * 2011-07-12 2016-03-30 天津药明康德新药开发有限公司 (4s)-1-取代-2,5-二氮杂双环[2,2,1]庚烷衍生物及制备方法
CN110184346A (zh) * 2019-07-11 2019-08-30 德阳市人民医院 男性骨质疏松症的诊断标志物

Also Published As

Publication number Publication date
CZ20024250A3 (cs) 2003-10-15
UY26809A1 (es) 2002-01-31
PE20030186A1 (es) 2003-03-23
KR20030014407A (ko) 2003-02-17
CN1443187A (zh) 2003-09-17
PL366565A1 (pl) 2005-02-07
TR200202702T2 (tr) 2004-12-21
IL152890A0 (en) 2003-06-24

Similar Documents

Publication Publication Date Title
UY28752A1 (es) Agentes terapeuticos
AR041055A1 (es) Derivados de benzoimidazol utiles como agentes antiproliferativos, composicion farmaceautica en base al compuesto y un procedimiento de preparacion del compuesto
AR012488A1 (es) Un compuesto derivado de quino- y quinazolinas antagonistas del factor liberador de corticotropina, un procedimiento para su preparacion, unacomposicion que los comprende, un procedimiento para la preparacion de dicha composicion, intermediarios y el uso de dichos compuestos para la fabricacion
AR023363A1 (es) Compuestos derivados de 3,3-biarilpiperidina y 2,2-biarilmorfolina, composicion y uso de los mismos
PE20020729A1 (es) Compuestos de succinimida heterociclicos fusionados y analogos de los mismos
HUP0402672A2 (hu) A nukleáris hormon receptor funkció kondenzált ciklikus modulátorai
IL146403A0 (en) Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
AR067475A1 (es) Antagonistas no basico s del receptor de la hormona concentradora de melanina 1
AR049646A1 (es) Derivados de sulfamato y sulfamida utiles para el tratamiento de la epilepsia y trastornos relacionados
ECSP045073A (es) Nuevos derivados de piperazina
CO5590904A2 (es) Esteriodes 3-nitrogen-6,7-dioxigeno y usos relacionados con este
CU23464B7 (es) (1,8)naftidirin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia
DK1255738T3 (da) Gonadotropin-frigivende hormonreceptor-antagonister og fremgangsmåder relateret dertil
ECSP066669A (es) Indoles, 1h-indazoles, 1,2-benzisoxazoles, y 1,2-benzisotiazoles, y preparación y usos de los mismos
TW200630361A (en) Integrin antagonists useful as anticancer agents
PA8541001A1 (es) Nuevos compuestos antiinflamatorios de triazolopiridinas
ES2061462T3 (es) Compuestos cefemo, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
CA2412161A1 (en) Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
MXPA05006420A (es) Derivados de pirimidina para el tratamiento de crecimiento celular anormal.
GT200600165A (es) Derivados dihidrobenzofuranos y usos de los mismos
SE0300119D0 (sv) Novel compounds
TW200732296A (en) Novel compounds
ECSP034898A (es) 2,5-DIARILPIRAZINAS, 2,5-DIARILPIRIDINAS y 2,5- DIARILPIRIMIDINAS
MA33242B1 (fr) Composes pour le traitement de troubles metaboliques
AR031709A1 (es) Compuestos ciclicos fusionados, las composiciones farmaceuticas que los contienen, los compuestos intermediarios en la preparacion de dichos compuestos ciclicos y los procedimientos para preparar dichos compuestos intermediarios

Legal Events

Date Code Title Description
FB Suspension of granting procedure